LIQUIDITY ALERT: Oscient Pharma Reports $11.37M Current Deficit

Subscribe
TOPICS: Biotechnology | Drugs/Pharmaceuticals | Earnings | Legal Issues, Litigation | Loans & Financing | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: Massachusetts | United States